Florida Oncology and Hematology Relocates Fort Myers Clinic
21. Januar 2025 08:00 ET
|
American Oncology Network
Florida Oncology and Hematology Relocates Fort Myers Clinic
Local oncology practice moves to a new location.
University Cancer & Blood Center physicians recognized among Atlanta’s Top Doctors in Modern Luxury Medicine + Doctors magazine
15. Januar 2025 14:14 ET
|
University, Cancer and Blood Center
Four physicians from University Cancer & Blood Center are recognized as Top Doctors in Modern Luxury Medicine + Doctors magazine.
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering
10. Januar 2025 08:00 ET
|
World Orphan Drug Alliance (WODA)
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering.
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
09. Januar 2025 16:00 ET
|
Aptose Biosciences, Inc.
Aptose Announces First AML Patients Dosed with
Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
30. Dezember 2024 08:00 ET
|
American Oncology Network
INDIANAPOLIS, IN., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of...
Hematology Analyzers and Reagents Market Share to Rise At 6.0% CAGR, To Hit USD 11.78 Billion by 2034 | PMR
11. Dezember 2024 06:46 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Market Details The global hematology analyzers and reagents market size is projected to grow from USD 6.57 billion in 2024 to USD 11.78 billion by...
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML
09. Dezember 2024 12:00 ET
|
Aptose Biosciences, Inc.
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML
Aptose Signs CRADA with NCI to Develop Tuspetinib for AML and MDS in Newly Launched MyeloMATCH Precision Medicine Trials
03. Dezember 2024 07:30 ET
|
Aptose Biosciences, Inc.
Aptose's AML drug tuspetinib selected for NCI's prestigious clinical research program for ability to target broad spectrum of AML and MDS populations
Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca's Soliris and Ultomiris
21. November 2024 09:27 ET
|
Spherix Global Insights
EXTON, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights has released its first annual chart audit study in hematology, Patient Chart Dynamix™ : Paroxysmal Nocturnal Hemoglobinuria (PNH)...
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21. November 2024 01:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Apheresis Equipment Market Size, Trends and Insights By Product Type...